Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Employees

2,650

Sector

Medical Equipment, Supplies & Distribution

Calendar

20/02 - Q4 2025 Earnings Release

More about the company

Quotes

Date	Price	Change	Volume
14/26/14	20.87 $	-0.14%	10,48,098
13/26/13	20.90 $	-2.11%	16,40,263
12/26/12	21.35 $	-1.61%	12,45,742
09/26/09	21.70 $	-3.56%	23,99,863
08/26/08	22.50 $	-0.92%	12,11,208

Delayed Quote Nasdaq, January 15, 2026 at 02:30 am IST

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

20.91USD

Average target price

25.71USD

Spread / Average Target

+22.99%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 02:30:00 15/01/2026 am IST			5-day change	1st Jan Change
20.87 ^USD	-0.14%		-11.34%	-5.05%

18/12	Tandem Diabetes Care, Inc. Announces Availability of the Tandem T:Slim Mobile Application for Android and iOS Users in Canada	CI
18/12	Truist Securities Adjusts Price Target on Tandem Diabetes Care to $24 From $17, Maintains Hold Rating	MT

Capitalization	141.75Cr 121.64Cr 113.26Cr 105.39Cr 196.68Cr 13TCr 212.02Cr 1.3TCr 512.26Cr 6.12TCr 531.64Cr 520.68Cr 22TCr	P/E ratio 2025 *	-7.66x	P/E ratio 2026 *	-20.8x
Enterprise value	138.33Cr 118.7Cr 110.52Cr 102.85Cr 191.93Cr 12TCr 206.9Cr 1.27TCr 499.88Cr 5.97TCr 518.79Cr 508.1Cr 22TCr	EV / Sales 2025 *	1.38x	EV / Sales 2026 *	1.09x
Free-Float	99.23%	Yield 2025 *	-	Yield 2026 *	-

18/12	Tandem Diabetes Care, Inc. Announces Availability of the Tandem T:Slim Mobile Application for Android and iOS Users in Canada	CI
18/12	Truist Securities Adjusts Price Target on Tandem Diabetes Care to $24 From $17, Maintains Hold Rating	MT
17/12	RBC Adjusts Price Target on Tandem Diabetes Care to $30 From $25, Maintains Outperform Rating	MT
17/12	North American Morning Briefing : Stock Futures, Oil Rise After Venezuela Blockade -2-	DJ
17/12	Tandem Diabetes Care Shares Rise After Baird Upgrade	MT
16/12	Baird Upgrades Tandem Diabetes Care to Outperform From Neutral, Adjusts PT to $30 From $18	MT
12/11	Tandem Diabetes Care, Inc. Appoints Sandra Beaver to Board of Directors, Effective November 7, 2025	CI
10/11	Tandem Says FDA Clears Tandem Mobi App Android Version	MT
10/11	Tandem Diabetes Care, Inc. Receives FDA Clearance for Use with Android Smartphones	CI
07/11	Tandem Diabetes Care, Inc., Q3 2025 Earnings Call, Nov 06, 2025
07/11	Tandem Diabetes Q3 sales rise 2%, gross margin improves	RE
07/11	Earnings Flash (TNDM) Tandem Diabetes Care, Inc. Reports Q3 Revenue $249.3M, vs. FactSet Est of $235.8M	MT
07/11	Tandem Diabetes Care, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

18/12	Truist Securities Adjusts Price Target on Tandem Diabetes Care to $24 From $17, Maintains Hold Rating	MT
17/12	RBC Adjusts Price Target on Tandem Diabetes Care to $30 From $25, Maintains Outperform Rating	MT
17/12	North American Morning Briefing : Stock Futures, Oil Rise After Venezuela Blockade -2-	DJ
17/12	Tandem Diabetes Care Shares Rise After Baird Upgrade	MT
16/12	Baird Upgrades Tandem Diabetes Care to Outperform From Neutral, Adjusts PT to $30 From $18	MT

Tandem Diabetes Care, Inc. Share Price

Equities

TNDM

US8753722037

Medical Equipment, Supplies & Distribution

Valuation: Tandem Diabetes Care, Inc.

Chart: Tandem Diabetes Care, Inc.

Latest news: Tandem Diabetes Care, Inc.

Last Transcript: Tandem Diabetes Care, Inc.

Analysts' recommendations: Tandem Diabetes Care, Inc.

Press Releases: Tandem Diabetes Care, Inc.

News in other languages: Tandem Diabetes Care, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Tandem Diabetes Care, Inc.

ETFs: Tandem Diabetes Care, Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

09/01	Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026	BU
31/12	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM	PR
26/12	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM	PR
18/12	Tandem t:slim Mobile App Now Available in Canada	BU
18/12	Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM	PR

18/12	L'application mobile Tandem t:slim est désormais disponible au Canada
04/25/04	L'application mobile Tandem t:slim est désormais autorisée par Santé Canada sur les téléphones iPhone et Android
10/24/10	La pompe à insuline Tandem t:slim X2 est désormais compatible avec la SGC Dexcom G7 au Canada
29/24/29	Tandem Diabetes Care et Dexcom annoncent que la pompe à insuline t:slim X2 compatible avec le système de SGC Dexcom G7 est autorisée à la vente par Santé Canada
05/23/05	Duolingo, Inc.: ¿Te gustaría tener un portafolio conmigo?

1 day	-0.14%
1 week	-11.34%
Current month	-5.05%
1 month	-2.43%
3 months	+50.47%
6 months	+33.87%
Current year	-5.05%

1 week	20.2	23.35
1 month	20.2	24.5
Current year	20.2	23.95
1 year	9.98	37.93
3 years	9.98	53.69
5 years	9.98	155.86
10 years	2.14	155.86

Manager	Title	Age	Since
John Sheridan CEO	Chief Executive Officer	70	01/03/2019
Leigh Vosseller DFI	Director of Finance/CFO	53	01/01/2018
Jean-Claude Kyrillos COO	Chief Operating Officer	62	21/06/2024

Director	Title	Age	Since
Christopher Twomey BRD	Director/Board Member	66	01/07/2013
John Sheridan BRD	Director/Board Member	70	01/06/2019
Rebecca Robertson CHM	Chairman	65	01/03/2023

Name		Varia. Jan 1.	Weight	AuM
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED		0.00%	0.45%	2 M€
CSIF (IE) MSCI USA SMALL CAP ESG LEADERS BLUE UCITS ETF B - USD		-.--%	0.32%	0 M€

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
TANDEM DIABETES CARE, INC.	-0.14%	-11.34%	-42.36%	-49.41%	141.71Cr
ABBOTT LABORATORIES	+0.56%	-2.18%	+10.43%	+10.12%	22TCr
MEDTRONIC PLC	+2.41%	-1.57%	+20.72%	+22.52%	12TCr
CENCORA, INC.	+1.17%	+1.09%	+48.22%	+113.01%	6.71TCr
BECTON, DICKINSON AND COMPANY	+2.93%	+1.00%	-12.18%	-18.93%	5.74TCr
HOYA CORPORATION	-1.29%	+2.19%	+26.60%	+95.65%	5.26TCr
MEDLINE INC.	+1.31%	+9.15%	-	-	3.57TCr
DEXCOM, INC.	-0.78%	-0.27%	-12.70%	-35.74%	2.74TCr
STERIS PLC	+1.69%	+1.62%	+27.43%	+30.80%	2.55TCr
SARTORIUS STEDIM BIOTECH	-2.33%	-5.11%	+2.89%	-34.22%	2.43TCr
Average	+0.56%	-0.08%	+7.67%	+14.87%	6.31TCr
Weighted average by Cap.	+0.97%	+0.15%	+15.31%	+25.87%

	2025 *	2026 *
Net sales	100.12Cr 86Cr 80Cr 74Cr 138.91Cr 9.04TCr 149.75Cr 919.69Cr 361.81Cr 4.32TCr 375.5Cr 367.76Cr 16TCr	110.06Cr 94Cr 88Cr 82Cr 152.7Cr 9.94TCr 164.62Cr 1.01TCr 397.73Cr 4.75TCr 412.77Cr 404.27Cr 17TCr
Net income	-18Cr -16Cr -15Cr -14Cr -25Cr -1.65TCr -27Cr -167.83Cr -66Cr -789.01Cr -69Cr -67Cr -2.89TCr	-6.91Cr -5.93Cr -5.52Cr -5.14Cr -9.59Cr -624.04Cr -10Cr -63Cr -25Cr -298.52Cr -26Cr -25Cr -1.09TCr
Net Debt	-3.42Cr -2.94Cr -2.74Cr -2.55Cr -4.75Cr -309.13Cr -5.12Cr -31Cr -12Cr -147.88Cr -13Cr -13Cr -541.86Cr	-22Cr -19Cr -17Cr -16Cr -30Cr -1.96TCr -33Cr -199.64Cr -79Cr -938.56Cr -82Cr -80Cr -3.44TCr